CoChat

DOT1L cooperates with the c-Myc–p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression

Open access

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

DOT1L has emerged as an anticancer target for MLL-associated leukaemias; however, its functional role in solid tumours is largely unknown. Here we identify that DOT1L cooperates with c-Myc and p300 acetyltransferase to epigenetically activate epithelial–mesenchymal transition (EMT) regulators in breast cancer progression. DOT1L recognizes SNAIL, ZEB1 and ZEB2 promoters via interacting with the c-Myc-p300 complex and facilitates lysine-79 methylation and acetylation towards histone H3, leading to the dissociation of HDAC1 and DNMT1 in the regions. The upregulation of these EMT regulators by the DOT1L-c-Myc-p300 complex enhances EMT-induced breast cancer stem cell (CSC)-like properties. Furthermore, in vivo orthotopic xenograft models show that DOT1L is required for malignant transformation of breast epithelial cells and breast tumour initiation and metastasis. Clinically, DOT1L expression is associated with poorer survival and aggressiveness of breast cancers. Collectively, we suggest that cooperative effect of DOT1L and c-Myc-p300 is critical for acquisition of aggressive phenotype of breast cancer by promoting EMT/CSC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms8821

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 DOT1L is associated with aggressive breast cancer by promoting EMT-induced breast tumour metastasis. (a) Analysis of overall and disease-free survival according to DOT1L expression in 91 ER-negative human breast cancers using Kaplan–Meier method with log-rank test. (b) The quantification of the association with DOT1L expression and invasion and metastasis in 182 human breast cancers. The P values were calculated by χ2-test. (c) Bright-field images of the indicated cell types for observation of changes in cell morphology after DOT1L overexpression and knockdown using lentiviruses encoding DOT1L cDNA or Tet-inducible DOT1L shRNA (shDOT1L), respectively. CON (control), empty vector; shCON, shRNA control. (d) The expression levels of epithelial and mesenchymal markers in the indicated cells were analysed using immunoblotting. (e,f) DOT1L-overexpressing MCF10A and its control cells were treated with 100 pM TGF-β1 for 48 h, and subjected to immunoblotting for analysis of DOT1L expression and activity (e). The invasion (upper) and migration (lower) by the indicated cells were analysed and quantified (f). * and †P<0.05 compared with CON/vehicle and CON/TGF-β, respectively (Student's t-test). (g) Analysis of invasion (left) and migration (right) by Tet-inducible DOTL-knockdown MDA-MB-231 cells. *P<0.05 versus shCON (Student's t-test). The data in f,g represent the means±s.d. of triplicate assays. (h) Effect of DOT1L on lung metastasis of breast cancer in xenografted mice. The in vivo experimental procedure was shown as a timeline (top). A representative images of histological analysis of lungs isolated from xenograft mice bearing Control (shCON) or Tet-inducible DOT1L-knockdown (shDOT1L)-MDA-MB-231 tumours (left). Arrowheads in the haematoxylin and eosin (H&E) image indicate lung metastatic nodules. To confirm DOT1L knockdown, immunohistochemical analysis of DOT1L expression was performed using lung tissues from the mice (bottom left). Data were quantified by counting the number of surface lung nodules (middle right) or assessing the incidence of lung metastasis in each group of mice (n=5; bottom right). Error bars indicate the means±s.e.m. *P<0.05 versus shCON (Student's t-test). Poisson distribution analysis was used for calculation of statistical significance of tumour incidence difference. Scale bars in c,f–h, 100 μm.
Figure 1 DOT1L is associated with aggressive breast cancer by promoting EMT-induced breast tumour metastasis. (a) Analysis of overall and disease-free survival according to DOT1L expression in 91 ER-negative human breast cancers using Kaplan–Meier method with log-rank test. (b) The quantification of the association with DOT1L expression and invasion and metastasis in 182 human breast cancers. The P values were calculated by χ2-test. (c) Bright-field images of the indicated cell types for observation of changes in cell morphology after DOT1L overexpression and knockdown using lentiviruses encoding DOT1L cDNA or Tet-inducible DOT1L shRNA (shDOT1L), respectively. CON (control), empty vector; shCON, shRNA control. (d) The expression levels of epithelial and mesenchymal markers in the indicated cells were analysed using immunoblotting. (e,f) DOT1L-overexpressing MCF10A and its control cells were treated with 100 pM TGF-β1 for 48 h, and subjected to immunoblotting for analysis of DOT1L expression and activity (e). The invasion (upper) and migration (lower) by the indicated cells were analysed and quantified (f). * and †P<0.05 compared with CON/vehicle and CON/TGF-β, respectively (Student's t-test). (g) Analysis of invasion (left) and migration (right) by Tet-inducible DOTL-knockdown MDA-MB-231 cells. *P<0.05 versus shCON (Student's t-test). The data in f,g represent the means±s.d. of triplicate assays. (h) Effect of DOT1L on lung metastasis of breast cancer in xenografted mice. The in vivo experimental procedure was shown as a timeline (top). A representative images of histological analysis of lungs isolated from xenograft mice bearing Control (shCON) or Tet-inducible DOT1L-knockdown (shDOT1L)-MDA-MB-231 tumours (left). Arrowheads in the haematoxylin and eosin (H&E) image indicate lung metastatic nodules. To confirm DOT1L knockdown, immunohistochemical analysis of DOT1L expression was performed using lung tissues from the mice (bottom left). Data were quantified by counting the number of surface lung nodules (middle right) or assessing the incidence of lung metastasis in each group of mice (n=5; bottom right). Error bars indicate the means±s.e.m. *P<0.05 versus shCON (Student's t-test). Poisson distribution analysis was used for calculation of statistical significance of tumour incidence difference. Scale bars in c,f–h, 100 μm.CC BY · PubMed Central
Figure 2 DOT1L is required for malignant transformation of breast epithelial cells and CSC-induced tumour initiation. (a) Lysates from stable DOT1L-expressing MCF10A and T47D cells and DOT1L siRNA (#1)-transfected MCF7 and MDA-MB-231 cells were subjected to immunoblotting for analysis of DOT1L and H3K79me2 expression (upper). The percentages of CD44+/CD24−/ESA+ breast CSC cells in the indicated cell lines were measured using flow cytometry (lower). siCON, control siRNA; siDOT1L, DOT1L siRNA. *P<0.05 versus controls (Student's t-test). (b) Tumoursphere formation assay was performed to evaluate self-renewal of CSCs in stable DOT1L-overexpressing and Tet-inducible DOT1L shRNA-expressing cells. shCON, pLKO-Tet control shRNA; shDOT1L, pLKO-Tet-DOT1L shRNA. *P<0.05 versus controls (Student's t-test). (c) Cell lines were generated by sequentially infecting MCF10A wild-type cells with activated HRAS and/or pLVX-DOT1L. Lysates from the indicated cells were then subjected to immunoblotting. (d) Morphological changes in the indicated cells were evaluated by microscopy (upper left). Images of invasion and migration assays in the indicated cells (middle and lower, left). Bars indicate measurements of invasion and migration abilities (right). *P<0.05 versus CON (Student's t-test). Results in (a,b,d) are shown as means±s.d. of experiments in triplicate. (e) The indicated stable MCF10A cells were orthotopically xenografted into NOD/SCID mice and tumour formation was monitored for 3 months. Representative tumour growth curves are shown. Error bars indicate the means±s.e.m. (n=5 mice). P values for multiple comparisons were calculated via repeated measures analysis of variance (RM ANOVA) followed by LSD post hoc test. *P=0.011 and 0.023, CON versus DOT1L and HRAS, respectively; ***P<0.001, CON versus DOT1L+HRAS; †††P<0.001, DOT1L versus DOT1L+HRAS. (f) Representative images of H&E staining and immunohistochemistry for DOT1L and E-cadherin in the xenograft tumours from the indicated groups of mice. Scale bars in d,f, 100 μm.
Figure 2 DOT1L is required for malignant transformation of breast epithelial cells and CSC-induced tumour initiation. (a) Lysates from stable DOT1L-expressing MCF10A and T47D cells and DOT1L siRNA (#1)-transfected MCF7 and MDA-MB-231 cells were subjected to immunoblotting for analysis of DOT1L and H3K79me2 expression (upper). The percentages of CD44+/CD24−/ESA+ breast CSC cells in the indicated cell lines were measured using flow cytometry (lower). siCON, control siRNA; siDOT1L, DOT1L siRNA. *P<0.05 versus controls (Student's t-test). (b) Tumoursphere formation assay was performed to evaluate self-renewal of CSCs in stable DOT1L-overexpressing and Tet-inducible DOT1L shRNA-expressing cells. shCON, pLKO-Tet control shRNA; shDOT1L, pLKO-Tet-DOT1L shRNA. *P<0.05 versus controls (Student's t-test). (c) Cell lines were generated by sequentially infecting MCF10A wild-type cells with activated HRAS and/or pLVX-DOT1L. Lysates from the indicated cells were then subjected to immunoblotting. (d) Morphological changes in the indicated cells were evaluated by microscopy (upper left). Images of invasion and migration assays in the indicated cells (middle and lower, left). Bars indicate measurements of invasion and migration abilities (right). *P<0.05 versus CON (Student's t-test). Results in (a,b,d) are shown as means±s.d. of experiments in triplicate. (e) The indicated stable MCF10A cells were orthotopically xenografted into NOD/SCID mice and tumour formation was monitored for 3 months. Representative tumour growth curves are shown. Error bars indicate the means±s.e.m. (n=5 mice). P values for multiple comparisons were calculated via repeated measures analysis of variance (RM ANOVA) followed by LSD post hoc test. *P=0.011 and 0.023, CON versus DOT1L and HRAS, respectively; ***P<0.001, CON versus DOT1L+HRAS; †††P<0.001, DOT1L versus DOT1L+HRAS. (f) Representative images of H&E staining and immunohistochemistry for DOT1L and E-cadherin in the xenograft tumours from the indicated groups of mice. Scale bars in d,f, 100 μm.CC BY · PubMed Central
Figure 3 DOT1L increases Snail, ZEB1 and ZEB2 expression to repress E-cadherin expression and breast CSC property. (a) CDH1 mRNA levels in the indicated cell lines were analysed using qRT–PCR. For transient knockdown of DOT1L, five different siRNAs against DOT1L (siDOT1L, #1–5) or siCON were transfected into MDA-MB-231 cells (middle). MCF10A cells expressing DOT1L wild-type (DOT1L) or DOT1L siRNA (#2)-resistant mutant (DOT1L-si MUT) were transfected with DOT1L siRNA #2 or control siRNA for 48 h, and subjected to qRT–PCR for analysis of CDH1 expression (right). *P<0.05 versus controls (CON, siCON, CON/siCON) by Student's t-test. (b) Effect of DOT1L on CDH1 promoter activity. Cells were transfected with luciferase constructs of wild-type (CDH1 pro-WT) or E-box-mutant (CDH1 pro-MUT) CDH1 promoters for 24 h and the luciferase activity was measured. RLU, relative light units. *P<0.05 versus CON (Student's t-test). (c–e) Effects of DOT1L on the expression of CDH1 transcriptional regulators were examined using immunoblotting (c), qRT–PCR (d) and immunofluorescence staining (e). *P<0.05 versus CON or siCON (Student's t-test). Scale bars in e, 100 μm. (f) Binding by EMT-TFs to the CDH1 promoter region was analysed using ChIP–qPCR. *P<0.05 versus CON (Student's t-test). (g,h) Effect of EMT-TFs on DOT1L-induced cancer stemness. Cells were transfected with siRNAs against Snail, ZEB1 and ZEB2, and the CSC population was measured using flow cytometry. The knockdown of EMT-TFs was confirmed by immunoblotting (g). The FACS results were quantified and shown as a bar graph (h). * and †P<0.05 versus CON/siCON and DOT1L/siCON, respectively (Student's t-test). Error bars in a,b,d,f,h indicate the means±s.d. of experiments in triplicate.
Figure 3 DOT1L increases Snail, ZEB1 and ZEB2 expression to repress E-cadherin expression and breast CSC property. (a) CDH1 mRNA levels in the indicated cell lines were analysed using qRT–PCR. For transient knockdown of DOT1L, five different siRNAs against DOT1L (siDOT1L, #1–5) or siCON were transfected into MDA-MB-231 cells (middle). MCF10A cells expressing DOT1L wild-type (DOT1L) or DOT1L siRNA (#2)-resistant mutant (DOT1L-si MUT) were transfected with DOT1L siRNA #2 or control siRNA for 48 h, and subjected to qRT–PCR for analysis of CDH1 expression (right). *P<0.05 versus controls (CON, siCON, CON/siCON) by Student's t-test. (b) Effect of DOT1L on CDH1 promoter activity. Cells were transfected with luciferase constructs of wild-type (CDH1 pro-WT) or E-box-mutant (CDH1 pro-MUT) CDH1 promoters for 24 h and the luciferase activity was measured. RLU, relative light units. *P<0.05 versus CON (Student's t-test). (c–e) Effects of DOT1L on the expression of CDH1 transcriptional regulators were examined using immunoblotting (c), qRT–PCR (d) and immunofluorescence staining (e). *P<0.05 versus CON or siCON (Student's t-test). Scale bars in e, 100 μm. (f) Binding by EMT-TFs to the CDH1 promoter region was analysed using ChIP–qPCR. *P<0.05 versus CON (Student's t-test). (g,h) Effect of EMT-TFs on DOT1L-induced cancer stemness. Cells were transfected with siRNAs against Snail, ZEB1 and ZEB2, and the CSC population was measured using flow cytometry. The knockdown of EMT-TFs was confirmed by immunoblotting (g). The FACS results were quantified and shown as a bar graph (h). * and †P<0.05 versus CON/siCON and DOT1L/siCON, respectively (Student's t-test). Error bars in a,b,d,f,h indicate the means±s.d. of experiments in triplicate.CC BY · PubMed Central
Figure 4 DOT1L epigenetically enhances EMT-TF expression in cooperation with histone acetyltransferases and c-Myc in the EMT-TF promoters. (a) Cells were treated with 1 μM EPZ004777 (EPZ) for 48 h and subjected to immunoblotting for analysis of Snail, ZEB1 and ZEB2 expression after inhibition of DOT1L enzymatic activity. (b) ChIP–qPCR analysis showing the amount of indicated proteins recruited to the promoter regions of Snail, ZEB1 and ZEB2. Data are presented as the means±s.d (n=3). *P<0.05 versus CON (Student's t-test). (c,d) The expression levels of EMT markers and transcriptional regulators were measured using immunoblotting after treatment of DOT1L-knockdown MDA-MB-231 cells with 5 μM 5'-Aza-2'-deoxycytidine (AZA) for 72 h and 100 ng ml−1 Trichostatin A (TSA) for 12 h. (e) The effect of DOT1L on c-Myc expression was analysed using immunoblotting. (f) Lysates from 293T cells transfected with DOT1L and/or c-Myc cDNA constructs were immunoprecipitated using the indicated antibodies and subjected to immunoblotting. (g) In vitro pull-down assay was performed to confirm the interaction between DOT1L and c-Myc. GST-c-Myc was used to pull down DOT1L from DOT1L-transfected 293T cell lysates. c-Myc-bound DOT1L was detected by indicated antibodies. Expression levels of DOT1L in 5% input were shown as indicated. Data are representative of three independent experiments.
Figure 4 DOT1L epigenetically enhances EMT-TF expression in cooperation with histone acetyltransferases and c-Myc in the EMT-TF promoters. (a) Cells were treated with 1 μM EPZ004777 (EPZ) for 48 h and subjected to immunoblotting for analysis of Snail, ZEB1 and ZEB2 expression after inhibition of DOT1L enzymatic activity. (b) ChIP–qPCR analysis showing the amount of indicated proteins recruited to the promoter regions of Snail, ZEB1 and ZEB2. Data are presented as the means±s.d (n=3). *P<0.05 versus CON (Student's t-test). (c,d) The expression levels of EMT markers and transcriptional regulators were measured using immunoblotting after treatment of DOT1L-knockdown MDA-MB-231 cells with 5 μM 5'-Aza-2'-deoxycytidine (AZA) for 72 h and 100 ng ml−1 Trichostatin A (TSA) for 12 h. (e) The effect of DOT1L on c-Myc expression was analysed using immunoblotting. (f) Lysates from 293T cells transfected with DOT1L and/or c-Myc cDNA constructs were immunoprecipitated using the indicated antibodies and subjected to immunoblotting. (g) In vitro pull-down assay was performed to confirm the interaction between DOT1L and c-Myc. GST-c-Myc was used to pull down DOT1L from DOT1L-transfected 293T cell lysates. c-Myc-bound DOT1L was detected by indicated antibodies. Expression levels of DOT1L in 5% input were shown as indicated. Data are representative of three independent experiments.CC BY · PubMed Central
Figure 5 c-Myc is required for formation of DOT1L-containing transcriptional active complex and recognition of DOT1L on EMT-TFs in regulation of breast CSC activity. (a) To confirm the binding of DOT1L or c-Myc with the indicated proteins, co-immunoprecipitation assays were performed using lysates from 293T cells transfected with the indicated constructs. (b) To investigate the effect of c-Myc on DOT1L-induced EMT-TF expression, lysates from CON or DOT1L-overexpressing MCF10A cells transfected with control or c-Myc siRNA (si c-Myc) were analysed by immunoblotting. (c) Dependency of EMT-TF regulation by DOT1L on c-Myc was confirmed using ChIP–qPCR assay in c-Myc siRNA-transfected MCF10A cells expressing DOT1L or its control cells. (d) The CSC population after c-Myc siRNA transfection was measured by FACS. Results in c,d are shown as means±s.d. of experiments in triplicate. * and †P<0.05 versus CON/siCON and DOT1L/siCON, respectively (Student's t-test). (e) A proposed model for the regulation by DOT1L of EMT-TFs. In the absence of DOT1L, c-Myc forms a repressive complex with DNMTs and HDACs in the E-box motif of the promoter regions of Snail, ZEB1 and ZEB2 EMT-TFs, which leads to DNA methylation at the CpG island and histone deacetylation within the promoters. When DOT1L is overexpressed, c-Myc interacts directly with the DOT1L complex containing HATs and recruits them to the promoter region of EMT-TFs. This leads to dissociation of DNMTs and HDACs from the promoters and enrichment of H3K79me and H3 acetylation in the region for activation of EMT-TF transcription. The enhanced expression of EMT-TFs induces EMT-associated CSC and metastasis.
Figure 5 c-Myc is required for formation of DOT1L-containing transcriptional active complex and recognition of DOT1L on EMT-TFs in regulation of breast CSC activity. (a) To confirm the binding of DOT1L or c-Myc with the indicated proteins, co-immunoprecipitation assays were performed using lysates from 293T cells transfected with the indicated constructs. (b) To investigate the effect of c-Myc on DOT1L-induced EMT-TF expression, lysates from CON or DOT1L-overexpressing MCF10A cells transfected with control or c-Myc siRNA (si c-Myc) were analysed by immunoblotting. (c) Dependency of EMT-TF regulation by DOT1L on c-Myc was confirmed using ChIP–qPCR assay in c-Myc siRNA-transfected MCF10A cells expressing DOT1L or its control cells. (d) The CSC population after c-Myc siRNA transfection was measured by FACS. Results in c,d are shown as means±s.d. of experiments in triplicate. * and †P<0.05 versus CON/siCON and DOT1L/siCON, respectively (Student's t-test). (e) A proposed model for the regulation by DOT1L of EMT-TFs. In the absence of DOT1L, c-Myc forms a repressive complex with DNMTs and HDACs in the E-box motif of the promoter regions of Snail, ZEB1 and ZEB2 EMT-TFs, which leads to DNA methylation at the CpG island and histone deacetylation within the promoters. When DOT1L is overexpressed, c-Myc interacts directly with the DOT1L complex containing HATs and recruits them to the promoter region of EMT-TFs. This leads to dissociation of DNMTs and HDACs from the promoters and enrichment of H3K79me and H3 acetylation in the region for activation of EMT-TF transcription. The enhanced expression of EMT-TFs induces EMT-associated CSC and metastasis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 223

Metadata

Authors
Cho, M.-H., Park, J.-H., Choi, H.-J., Park, M.-K., Won, H.-Y., Park, Y.-J., Lee, C. H., Oh, S.-H., Song, Y.-S., Kim, H. S., Oh, Y.-H., Lee, J.-Y., & Kong, G.
Affiliations
  • Hanyang University (KR)
  • Dongguk University (KR)
  • Gachon University (KR)
Corresponding author
  • Lee, Jeong-Yeon
  • Kong, Gu
Venue
Nature Communications
Published
2015-07-22
Volume
6
Issue
1
Pages
7821-7821
ISSN
2041-1723 (ISSN-L)
OpenAlex
W1620051969
Cited by
211
References
39
Citations by year
2026: 7 · 2025: 14 · 2024: 19 · 2023: 21 · 2022: 29 · 2021: 24 · 2020: 22 · 2019: 20 · 2018: 10 · 2017: 18 · 2016: 23 · 2015: 3
FWCI
7.82
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • The Royal Society of Chemistry’s Journals, Books and Databases (The Royal Society of Chemistry) (submittedVersion)
  • The Royal Society of Chemistry’s Journals, Books and Databases (The Royal Society of Chemistry) (submittedVersion, cc-by)
Funders
  • National Research Foundation
  • National Research Foundation of Korea
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
Keywords
DOT1L, c-Myc, P300, epithelial-mesenchymal transition, breast cancer progression, histone H3 lysine 79 methylation, histone acetylation, snails, ZEB1, ZEB2, HDAC1, DNMT1, breast cancer stem cells, metastasis, tumor initiation
MeSH terms
Animals, Breast Neoplasms, Female, Humans, Methyltransferases, Neoplasm Metastasis, Histone-Lysine N-Methyltransferase, Neoplastic Stem Cells, Case-Control Studies, Proto-Oncogene Proteins c-myc, Mice, SCID, Mice, Inbred NOD, Disease Progression, Epigenesis, Genetic, Cell Line, Tumor, E1A-Associated p300 Protein, Epithelial-Mesenchymal Transition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.